CompletedNot applicableNCT02985684

Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

Studying Interatrial communication

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: W.L.Gore & Associates
Principal Investigator: Robert Sommer, MD
Columbia University of New York
Intervention: GORE® CARDIOFORM ASD Occluder(device)
Enrollment: 125 target
Eligibility: All sexes
Timeline: 2017 – 2022

Study locations (22)

Phoenix Children's Hospital, Phoenix, Arizona, United States
University of California-Los Angeles, Los Angeles, California, United States
The Children's Hospital of Colorado, Aurora, Colorado, United States
Yale University School of Medicine, New Haven, Connecticut, United States
Nicklaus Children's Hospital, Miami, Florida, United States
Children's Healthcare at Egleston, Atlanta, Georgia, United States
Riley Hospital for Children, Indianapolis, Indiana, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Children's Hospital Boston, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
Children's Hospital of Michigan, Detroit, Michigan, United States
Mayo Clinic - Rochester, Rochester, Minnesota, United States
Mount Sinai Medical Center, New York, New York, United States
Columbia University Medical Center/New York Presbyterian Hospital, New York, New York, United States
Atrium Health, Charlotte, North Carolina, United States
+7 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02985684 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication →

← Back to all trials